More Access to Clinical Trials for Cancer Patients

Memorial Sloan Kettering in New York City is known for innovative cancer treatment and research. Now, patients undergoing treatment at the Hartford HealthCare Cancer Institute, including Hartford Hospital, have access to those promising and potentially groundbreaking advances in research and treatment without traveling to New York City.

Access to leading-edge clinical trials is part of the Hartford HealthCare Cancer Institute’s membership in the MSK Cancer Alliance, which brings state-of-the-art standards of care into communities.

MSK clinical trials and research protocols are available to patients treated at any of the five cancer centers that make up the Hartford HealthCare Cancer Institute – Hartford Hospital, Backus Hospital, Windham Hospital, The Hospital of Central Connecticut and MidState Medical Center.

The trials are open to patients for the treatment of a variety of cancer types, including breast cancer, bladder cancer, pancreatic cancer and ovarian cancer, as well as multiple myeloma. Upcoming studies are expected to be opened for patients with colorectal and lung cancer, as well as Hodgkin and non-Hodgkin lymphoma.

“Our goal is to add to our existing portfolio of studies and to offer a comprehensive array of clinical trials for patients with common and uncommon cancers treated at the Hartford HealthCare Cancer Institute,” said Ellen Dornelas, PhD, director of the Cancer Clinical Research Office.